Hematology Information Center


A Novel and Rapid Assay for Sickle Cell Disease Screening

A Novel and Rapid Assay for Sickle Cell Disease Screening

Children born with sickle cell disease in low-resource regions of the world often remain undiagnosed and therefore do not receive appropriate treatment.

FDA Approves New DNA-Based Test to Verify Blood Compatibility

Assay can be used to determine blood donor and patient non-ABO red blood cell types.

Heat-Stable Carbetocin Safe Alternative to Oxytocin for Postpartum Hemorrhage Prevention

Heat-stable carbetocin — an analog of oxytocin — was found to be noninferior to oxytocin in preventing hemorrhage associated with vaginal birth and may be beneficial in low- and middle-income countries.

Red Cross Calls for Blood Donors

While all blood types are needed, type O negative and positive are especially crucial.

Blood transfusion from female donors with history of pregnancy linked to increased mortality risk in men

Males who receive a blood transfusion from an ever-pregnant female donor have an increased mortality risk compared with those who receive a transfusion from a male donor or never-pregnant female.

Radiation exposure and cancer risk from CT screening: a risk-benefit analysis

After 10 years of low-dose CT screening in patients, 1.5 lung cancers and 2.4 major cancers per 10,000 people screened were induced by radiation.

FDA approves 'breakthrough therapy' for CLL

Gazyva is designed to bolster the immune system's ability to attack cancer cells.

Gleevec approved for pediatric acute lymphoblastic leukemia

Imatinib belongs to a class of drugs called tyrosine kinase inhibitors and blocks proteins that promote development of cancer cells.

Ponatinib wins early approval for rare leukemias

The FDA has approved ponatinib to treat chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia.

Bosutinib approved for chronic myelogenous leukemia

The FDA has approved bosutinib (Bosulif, Pfizer) for patients with chronic, accelerated or blast phase Philadelphia chromosome positive CML, who are resistant to or who cannot tolerate other therapies.


Case Study: A subdural hematoma after a fall

Case Study: A subdural hematoma after a fall

A 65-year-old Hispanic man presents to the emergency department via EMS after an unwitnessed fall from a presumed standing height.

Is there an occupational cancer risk with flying?

Is there an occupational cancer risk with flying?

Has any research been conducted to determine whether the incidence of various types of skin cancer is greater in people who fly for a living compared with the general public?

Sign Up for Free e-newsletters